文献速递疝与腹壁外科围术期管理与 ERAS

非血管化腹直肌筋膜作为跨学科同种移植物的适应症扩展:一项前瞻性单中心研究

Expanding Indications of Nonvascularized Rectus Fascia as a Cross-Disciplinary Allograft: A Prospective Single-Center Study.
PubMed 文献 · Ann Surg · 2026-09-03

该前瞻性单中心研究纳入2020至2025年连续接受非血管化腹直肌筋膜同种移植(NVRF-alloTx)的患者,分为实体器官移植(SOT)组和非SOT组,评估其用于复杂腹部和胸部重建的有效性、整合及免疫反应。

要点

  • NVRF-alloTx在SOT和非SOT患者的复杂缺损重建中可行且有效。
  • 移植物未整合率为4.9%,与胰漏和血管加压药治疗相关。
  • 非SOT受者比SOT受者更易产生HLA供者特异性抗体。

核心结论

  • NVRF-alloTx是SOT和非SOT患者复杂缺损的多功能有效重建选择,在挑战性临床场景中提供传统补片替代方案。

主要发现

  • 组织学(n=5)显示移植物通过宿主纤维化重塑整合,自植入后1个月可见新生血管。
  • 非SOT NVRF受者比SOT NVRF受者更频繁发生(新发)HLA-DSA。

临床怎么用

  • 对于复杂腹部和胸部缺损,NVRF-alloTx可作为传统合成或生物补片的替代选择。
  • 非SOT受者需关注HLA-DSA形成风险,SOT受者免疫抑制状态可能影响免疫反应。

局限性

  • 单中心前瞻性研究,样本量有限(41例患者)。
  • 组织学评估仅5例,免疫学数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the expanding application of nonvascularized rectus fascia allotransplantation (NVRF-alloTx) in solid organ transplant (SOT) and non-SOT patients and evaluate its effectiveness, integration, and immunologic response in complex abdominal and thoracic reconstruction. SUMMARY BACKGROUND DATA: Synthetic and biological meshes are limited by infection risk, long-term failure, donor-site morbidity, and high cost. NVRF-alloTx, first applied in intestinal/multivisceral-Tx with a 5.9% herniation rate, offers a simple and promising alternative for challenging defects. METHODS: This prospective single-center study included all consecutive patients undergoing NVRF-alloTx (2020-2025). Patients were divided into 2 groups: (1) reconstruction in SOT patients (simultaneous or elective closure post-SOT) and (2) reconstruction in non-SOT patients, without immunosuppression. NVRF-allografts were procured from deceased donors, preserved at 2°C, and implanted without HLA-matching. Primary endpoints were successful closure, graft failure, and functional outcome. Clinical and radiologic follow-up was performed, with HLA donor-specific antibody (HLA-DSA) testing and histology whenever available. RESULTS: Forty-seven NVRF-Tx procedures were performed in 41 patients using grafts from 48 deceased donors: group 1 (n=17) and group 2 (n=24). In 2 patients (4.9%), the graft did not integrate due to pancreatic leakage and vasopressor therapy. Others resulted in successful functional outcomes. Histology (n=5) showed graft integration through host fibrotic remodeling with neovascularization evident from 1 month after implantation. (De novo) HLA-DSA developed more frequently in non-SOT NVRF recipients than in SOT NVRF recipients. CONCLUSIONS: NVRF-alloTx is a versatile and effective reconstructive option for complex defects in SOT and non-SOT patients, providing an alternative to conventional meshes in challenging clinical scenarios.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ceulemans LJ, Muylle E, De Hertogh G, et al. Expanding Indications of Nonvascularized Rectus Fascia as a Cross-Disciplinary Allograft: A Prospective Single-Center Study. Ann Surg. 2026. PMID: 42690913. doi:10.1097/SLA.0000000000007194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。